Antiphospholipid Syndrome Associated with Lung Embolism: A Case ReportCorrespondence Address :
Dr. Mohammed Alaidarous,
Assistant Professor, Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah Universtiy,
Al-Majmaah, PO-Box 66, Zipcode-11952, Riyadh, Saudi Arabia.
Antiphospholipid Syndrome (APS) is an autoimmune disease, where the immune system antibodies damage and attack the body’s own cells and tissues. Antibodies are proteins that protect the body against infections. Cells are damaged when these autoantibodies attack the phospholipids causing blood clots in the veins and arteries. An individual is diagnosed with APS if tested positive for autoantibodies and have a history of autoimmune diseases. Here, the case of a 33-year-old Saudi male is being reported, who was diagnosed with APS, treated with warfarin. The available knowledge about this disease and its relevance to the symptoms of the patient was also summerised.
Adult, Antiphospholipid antibodies, Saudi arabia, Thrombosis, Warfarin
Mohammed Alaidarous. ANTIPHOSPHOLIPID SYNDROME ASSOCIATED WITH LUNG EMBOLISM: A CASE REPORT. Journal of Clinical and Diagnostic Research [serial online] 2018 May [cited: 2018 May 25 ]; 12:OD03-OD04. Available from
Date of Submission: Dec 05, 2017
Date of Peer Review: Dec 26, 2017
Date of Acceptance: Feb 28, 2018
Date of Publishing: May 01, 2018
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)